Five-Year Prognostic Value of DAPT Score in Older Patients undergoing Percutaneous Coronary Intervention: A Large-Sample Study in the Real World
Journal of Atherosclerosis and Thrombosis · 01.08.2023 · 30 (8) · 1057-1069
DOI: 10.5551/jat.64212 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Atherosclerosis and Thrombosis, erschienen am 01.08.2023. Verfasst von Kailun Yan und 11 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fu Wai Hospital, National Center for C…. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Myocardial Infarction. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
AIM: The dual-antiplatelet therapy (DAPT) score is recommended for predicting the risk of ischemia and bleeding for patients undergoing percutaneous coronary intervention (PCI). This study aimed to investigate the long-term prognostic value of the DAPT score in older PCI patients. METHODS: This study enrolled 10,724 consecutive patients who underwent PCI from January 2013 to December 2013 in Fu Wai hospital, among whom 2,981 (27.8%) were aged ≥ 65 years. The ischemic endpoint was major adverse cardiovascular and cerebrovascular events (MACCE, including myocardial infarction, all-cause death, and stroke). The bleeding endpoint was Bleeding Academic Research Consortium (BARC) 2, 3, or 5 bleeding. RESULTS: After a 5-year follow-up, 256 (12.0%) MACCEs and 53 (2.5%) BARC 2, 3, or 5 bleeding occurred. The patients were divided into two groups according to the DAPT score: the low-score (<2, n=1,646) and high-score (≥ 2, n=485) group. Multivariate Cox regression revealed that the risk of MACCE was similar between the two groups [hazard ratio (HR): 1.214, 95% confidence interval (CI): 0.916-1.609, P=0.178], whereas the risk of bleeding was significantly higher in the high-score group than in the low-score group (HR: 2.447, 95% CI: 1.407-4.257, P=0.002). The DAPT score did not show prognostic value in MACCE [area under the receiver operating characteristic curve (AUROC), 0.534; 95% CI: 0.496-0.572, P=0.079]; however, it demonstrated a certain prognostic value in BARC 2, 3, or 5 bleeding (AUROC, 0.646; 95% CI: 0.573-0.719, P<0.001). CONCLUSION: This study suggested that in older PCI patients, the DAPT score did not show predictive value for MACCE; however, it had a certain predictive value for 5-year BARC 2, 3, or 5 bleeding.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking…
Zitieren
APA
Yan, K., Zhu, P., Tang, X., Li, Y., Li, J., Yuan, D., Yang, W., Yang, Y., Gao, R., Xu, B., Yuan, J., & Zhao, X. (2023). Five-Year Prognostic Value of DAPT Score in Older Patients undergoing Percutaneous Coronary Intervention: A Large-Sample Study in the Real World. Journal of Atherosclerosis and Thrombosis, 30(8), 1057-1069. https://doi.org/10.5551/jat.64212
Vancouver
Yan K, Zhu P, Tang X, Li Y, Li J, Yuan D, et al. Five-Year Prognostic Value of DAPT Score in Older Patients undergoing Percutaneous Coronary Intervention: A Large-Sample Study in the Real World. Journal of Atherosclerosis and Thrombosis. 2023;30(8):1057-1069. doi:10.5551/jat.64212
BibTeX
@article{Yan2023,
author = {Yan, Kailun and Zhu, Pei and Tang, Xiaofang and Li, Yulong and Li, Jiawen and Yuan, Deshan and Yang, Weixian and Yang, Yuejin and Gao, Runlin and Xu, Bo and Yuan, Jinqing and Zhao, Xueyan},
title = {Five-Year Prognostic Value of DAPT Score in Older Patients undergoing Percutaneous Coronary Intervention: A Large-Sample Study in the Real World},
journal = {Journal of Atherosclerosis and Thrombosis},
year = {2023},
volume = {30},
number = {8},
pages = {1057--1069},
doi = {10.5551/jat.64212}
}
EUVIMED